Shopping Cart
Remove All
Your shopping cart is currently empty
Quisovalimab is a therapeutic monoclonal antibody targeting interleukin-11 (IL-11), showing significant anti-inflammatory and anti-fibrotic effects by blocking IL-11 signaling.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $647 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $987 | 2-4 weeks | 2-4 weeks |
| Description | Quisovalimab is a therapeutic monoclonal antibody targeting interleukin-11 (IL-11), showing significant anti-inflammatory and anti-fibrotic effects by blocking IL-11 signaling. |
| Synonyms | SAR 252067, MDGN-002, CERC-002, AVTX-002, AEVI 002 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | LIGHT |
| Cas No. | 2427667-03-4 |
| Isotype | IgG4 (S228P) |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.